Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Patent Extensions’ Cost To Be Evaluated By FDA Under Ag Approps Request

Nov 19 2001

• By The Pink Sheet

Related Content

FDA Patent Listing Procedures May Need Revision, Hatch And Waxman Say

Sep 10 2001

Generic Reform Advocates See Reimport Bill As Model: Is Hatch Obstacle?

May 14 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window